logo
Plus   Neg
Share
Email

Boston Scientific Acquires NVision Medical In Up To $275 Mln Deal - Quick Facts

Boston Scientific Corp. (BSX) announced Monday it has acquired privately-held nVision Medical Corp. which is focused on women's health.

nVision developed the first and only device cleared by the U.S. Food and Drug Administration to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer.

The deal consists of an upfront cash payment of $150 million, and up to an additional $125 million in potential clinical and commercial milestones over four years.

The deal is expected to be immaterial on an adjusted basis in 2018 and 2019, and accretive thereafter through 2020 and less accretive thereafter due to amortization expense and acquisition costs.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Bahrain's foreign minister has called for a boycott of Uber after the ride-hailing company's Chief Executive Officer Dara Khosrowshahi said he will not attend an investment conference in Bahrain's ally, Saudi Arabia. Khosrowshahi is among several business leaders who have said they are pulling out of the three-day investment conference slated to take place in Saudi Arabia beginning October 23. Porsche, the sports car maker owned by Volkswagen AG, has denied speculation that it plans to pursue an initial public offering or IPO. Porsche Chief Financial Officer Lutz Meschke said on Friday that Porsche was discussing a potential listing of a group combining Porsche, Bentley, Lamborghini and Bugatti, with a potential value of up to 70 billion euros. Bank of America (BAC) reported that its third-quarter earnings per share was up 43% year-over-year to $0.66. On average, 24 analysts polled by Thomson Reuters expected the company to report profit per share of $0.62 for the quarter. Analysts' estimates typically exclude special items. Net income to shareholders...
Follow RTT